November 22, 2004
(Date of earliest event reported)
LABORATORY CORPORATION
OF
AMERICA HOLDINGS
DELAWARE | 1-11353 | 13-3757370 | ||
(State or other jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA |
27215 | 336-229-1127 | ||
(Address of principal executive offices) | (Zip Code) |
(Registrant's telephone number including area code) |
ITEM 7.01. Regulation FD Disclosure
On November 22, 2004 Laboratory Corporation of America® Holdings (LabCorp®) announced the availability of an innovative new chart-based laboratory order entry and results delivery system called FirstChart. The FirstChart product was developed in collaboration with one of LabCorps strategic connectivity partners, Allscripts Healthcare Solutions, to help accelerate electronic medical record adoption by providing physician clients with a state-of-the-art connectivity solution that can be customized for their specific practices.
Exhibits
99.1 Press Release dated November 22, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Laboratory Corporation of America Holdings (Registrant) |
||||
Date: November 22, 2004 | By: | /s/Bradford T. Smith | ||
Bradford T. Smith, Executive Vice President and Secretary |
||||
FirstChart Allows Clients to Customize Connectivity Technology to Their Practices
Burlington, N.C., November 22, 2004 Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the availability of an innovative new chart-based laboratory order entry and results delivery system called FirstChart. The FirstChart product was developed in collaboration with one of LabCorps strategic connectivity partners, Allscripts Healthcare Solutions (Nasdaq: MDRX), to help accelerate electronic medical record adoption by providing physician clients with a state-of-the-art connectivity solution that can be customized for their specific practices.
The FirstChart product integrates LabCorps unique and comprehensive laboratory processing abilities with Allscripts electronic medical record (EMR) technology, patient chart viewing and enhanced workflow capabilities. FirstChart is designed to help LabCorp customers migrate toward the use of electronic medical record and other technology workflow solutions, such as e-prescribing and document imaging.
Also, as part of LabCorps physician-focused connectivity strategy, the company has hired a team of experienced healthcare technology consultants to work daily with its national sales team to resolve the complex technology and connectivity issues often faced by physician offices.
We are very excited about our expanded relationship with Allscripts Healthcare Solutions, as well as our joint involvement in the national movement to promote the use of electronic health records, said Bill Haas, LabCorps executive vice president of sales and marketing. LabCorp has an adaptable connectivity strategy that allows us to connect with our clients existing systems while maintaining the ability to accommodate future system updates. We recognize that clients need the ability to choose the systems that best meet their needs. By continuing to build relationships with the top healthcare technology vendors, we ensure LabCorp physician clients not only have access to the best technology, they also have choice.
We are pleased that LabCorp will be including our software in its FirstChart solution. As one of the nations leading laboratory service providers, LabCorps deployment of our software will help make Allscripts ubiquitous in physician practices, commented Glen Tullman, chairman and chief executive officer of Allscripts. This new initiative reinforces LabCorps healthcare IT leadership by helping physicians take important steps on the road toward the adoption of a complete electronic medical record.
About LabCorp
Laboratory Corporation of America®
Holdings is a pioneer in commercializing new diagnostic technologies and the first in its
industry to embrace genomic testing. With annual revenues of $2.9 billion in 2003,
approximately 23,000 employees nationwide, and more than 220,000 clients, LabCorp offers
over 4,400 clinical assays ranging from blood analyses to HIV and genomic testing. LabCorp
combines its expertise in innovative clinical testing technology with its Centers of
Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC;
National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in
Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; and DIANON
Systems, Inc. based in Stratford, CT. LabCorp clients include physicians,
government agencies, managed care organizations, hospitals, clinical labs, and
pharmaceutical companies. To learn more about our growing organization, visit our web site
at: www.LabCorp.com.
About Allscripts
Healthcare Solutions
Allscripts Healthcare Solutions (AHS)
is the leading provider of clinical software, connectivity and information solutions that
physicians use to improve healthcare. The Companys TouchWorks software is a modular
Electronic Medical Record (EMR) that enhances physician productivity by automating the
most common physician activities including prescribing, dictating, capturing charges,
ordering labs and viewing results, providing patient education, and documenting clinical
encounters. TouchWorks is available on the latest Tablet PCs, wireless handheld devices,
desktop workstations and over the Internet. AHS also offers electronic document imaging
and scanning solutions through its Advanced Imaging Concepts (AIC) subsidiary.
Additionally, AHS provides healthcare product education and market research programs for
physicians through its Physicians Interactive(tm) unit and medication fulfillment services
through its Allscripts Direct(tm) unit. Visit AHS on the Web at www.allscripts.com.
Strategic partners include IDX Systems, IMS Health, Microsoft, Hewlett-Packard Company,
and Medco Health.
Each of the above forward-looking statements is subject to change
based on various important factors, including without limitation, competitive actions in
the marketplace and adverse actions of governmental and other third-party payors. Actual
results could differ materially from those suggested by these forward-looking statements.
Further information on potential factors that could affect LabCorps financial
results is included in the Companys Form 10-K for the year ended December 31, 2003,
and subsequent SEC filings.